.jpg)
HCRI was founded by Ronald L. Webster, Ph.D. in 1972 to investigate stuttering with scientific methods and new treatment approaches. Under Dr. Webster´s direction, Virginia-based HCRI, a nonprofit organization, has become an international leader in stuttering research and the development of innovative, scientifically based therapy approaches.
The Institute's work has enabled the definition of specific speech behaviors that replace the distorted muscle activities that produce stuttering. This has led to therapy developments, ongoing treatment refinements, and the creation of new treatment tools that enhance fluency outcomes. U.S. patents have been awarded to HCRI for some of these stuttering therapy innovations.
Our research scientists have tested and retested HCRI´s therapy system with thousands of people who stutter. In addition, we have created new ways to use technology in therapy that make the learning of lasting fluency skills straightforward and practical.
Each of HCRI's intensive stuttering therapy programs lasts 12 days. The Institute´s research demonstrates that 93% of program participants achieve fluency by the conclusion of treatment. When evaluated two years post therapy, 75% of participants retain fluent speech. For more information on HCRI stuttering treatment and results, click here
HCRI clinicians have treated more than 6,500 individuals, aged 11 to 73, from across the U.S. and 50 countries. Clients include broadcaster John Stossel of Fox News; Annie Glenn, wife of Senator and Astronaut John Glenn; as well as athletes, teachers, engineers, students, doctors, military personnel, business professionals, police officers, actors, paramedics, and other individuals from all walks of life.
Before coming to HCRI, most program participants tried other therapies for stuttering without long-term success. HCRI´s approach is designed to teach fluency skills that can be maintained for a lifetime.
1. Come to HCRI.
2. Get the right therapy.
3. Return home to a better life through fluency.
Contact us to inquire about availability for HCRI's 12-day therapy program.
